Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2025-12-26 @ 1:56 AM
Study NCT ID:
NCT00375505
Status:
COMPLETED
Last Update Posted:
2015-09-07
First Post:
2006-09-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2014-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-11
First Submit QC Date:
None
Study First Post Date:
2006-09-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-18
Results First Submit QC Date:
None
Results First Post Date:
2015-09-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-11
Last Update Post Date:
2015-09-07
Last Update Post Date Type:
ESTIMATED